Nutex Health (NUTX) vs Radware (RDWR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Radware (RDWR) has outperformed Nutex Health (NUTX) over the past year, gaining 45.7% versus a gain of 18.8%. Radware is the larger company by market cap ($1.36 billion vs $1.12 billion), about 1.2 times the size, while Nutex Health is growing revenue faster (+82.4% vs +9.8%). On valuation, Nutex Health trades at a lower forward P/E (8.0x vs 22.8x for Radware).
Nutex Health converts more of its revenue into profit, with a net margin of 8.1% versus 6.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NUTX | RDWR |
|---|---|---|
| Share price | $162.64 | $32.22 |
| Market cap | $1.12B | $1.36B |
| 1-day change | +0.33% | -4.51% |
| YTD return | -1.20% | +33.75% |
| 1-year return | +18.78% | +45.73% |
| 5-year return | — | +9.67% |
| P/E ratio (TTM) | 7.04 | 68.55 |
| Forward P/E | 8.00 | 22.80 |
| EPS (TTM) | $23.11 | $0.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $875.26M | $301.85M |
| Revenue growth (YoY) | +82.36% | +9.81% |
| Net income (latest FY) | $70.79M | $20.26M |
| Gross margin | 50.76% | 80.67% |
| Operating margin | 31.49% | 3.78% |
| Net margin | 8.09% | 6.71% |
| 52-week high | $226.16 | $38.50 |
| 52-week low | $83.99 | $21.92 |
| Distance from 52-week high | -28.09% | -16.31% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +92.86% | +28.80% |
| Average volume | 149.94K | 392.25K |
| Shares outstanding | 6.86M | 42.08M |
| Employees | 1,093 | 1,228 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Business Services | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RDWR has outperformed NUTX by 26.9 percentage points over the past year.
- Radware trades at a higher earnings multiple (68.6x vs 7.0x trailing P/E).
- Nutex Health grew revenue faster in its latest fiscal year (+82.36% vs +9.81%).
About Nutex Health
NUTX stock →Nutex Health Inc. operates as a healthcare services and operations company in the United States.
Consumer Discretionary · Business Services · 1,093 employees
About Radware
RDWR stock →Radware Ltd., together with its subsidiaries, develops, manufactures, and markets cyber security and application delivery solutions for cloud, on-premises, and software defined data centers. The company operates in two segments, Radware's Core Business and The Hawks' Business.
Consumer Discretionary · Business Services · 1,228 employees
NUTX vs RDWR FAQ
Which is bigger, Nutex Health or Radware?
Radware (RDWR) is larger, with a market capitalization of $1.36B compared with $1.12B for Nutex Health (NUTX).
Which stock has performed better over the past year, NUTX or RDWR?
RDWR returned +45.73% over the past 12 months, compared with +18.78% for NUTX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, NUTX or RDWR?
NUTX has the lower trailing P/E at 7.0, versus 68.6 for RDWR. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Nutex Health and Radware in the same industry?
Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.